XML 51 R13.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Components
6 Months Ended
Jul. 26, 2015
Notes to financial statements [Abstract]  
Balance Sheet Components
Balance Sheet Components
 
Certain balance sheet components are as follows:
 
July 26,
 
January 25,
 
2015
 
2015
Inventories:
(In millions)
Raw materials
$
139

 
$
157

Work in-process
107

 
92

Finished goods
195

 
234

Total inventories
$
441

 
$
483



At July 26, 2015, we had outstanding inventory purchase obligations totaling $487 million.

 
July 26,
 
January 25,
 
2015
 
2015
Accrued and Other Current Liabilities:
(In millions)
Unearned revenue (1)
$
321

 
$
296

Customer related liabilities (2)
130

 
143

Accrued payroll and related expenses
111

 
112

Warranty accrual (3)
28

 
8

Professional service fees
29

 
17

Accrued restructuring and other charges (4)
18

 

Coupon interest on Notes
3

 
3

Taxes payable
3

 
3

Facilities related liabilities
1

 
8

Other
15

 
13

Total accrued and other current liabilities
$
659

 
$
603

      
(1)
Unearned revenue primarily includes deferred revenue.
(2)
Customer related liabilities primarily includes accrued customer programs. Please refer to Note 1 of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended January 25, 2015, for discussion regarding the nature of accrued customer programs and their accounting treatment related to our revenue recognition policies and estimates. 
(3)
Please refer to Note 9 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the warranty accrual.
(4)
Please refer to Note 14 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the restructuring and other charges accrual.
 
July 26,
 
January 25,
 
2015
 
2015
Other Long-Term Liabilities:
(In millions)
Deferred income tax liability
$
292

 
$
232

Income taxes payable
124

 
121

Asset retirement obligation
7

 
7

Deferred revenue (1)
1

 
108

Other
23

 
21

Total other long-term liabilities
$
447

 
$
489



(1) Consists primarily of consideration received in advance of our performance obligations under the patent cross licensing agreement that we entered into with Intel Corporation in January 2011. The decrease in deferred revenue, long-term, is a result of revenue recognized during the six months ended July 26, 2015.